Baillie Gifford acquired 13.4 Million Royalty Pharma plc shares worth $444 Million. That's 0.37% of their equity portfolio (53rd largest holding). The investor owns 3.11% of the outstanding Royalty Pharma plc stock. The first Royalty Pharma plc trade was made in Q1 2022. Since then Baillie Gifford bought shares two more times and sold shares on ten occasions. The investor's estimated purchase price is $544 Million, resulting in a loss of 18%.